Screening and Multiple Intervention on Lung Epidemics
Status:
Active, not recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
This prospective randomized pilot trial will evaluate a multiple intervention program of
prevention in lifelong smokers aiming at reduction of chronic inflammation status through
treatment with low-dose acetylsalicylic acid (ASA), smoking cessation with cytisine, targeted
modification of diet and physical activity, in addition to early diagnosis with annual ultra
low-dose spiral computed tomography (LDCT).
Phase:
Phase 2
Details
Lead Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano